ClinicalTrials.gg
Drug

Isotretinoin clinical trials

Also written Accutane, 13-cis-retinoic acid, Amnesteem and RO-43.

studies test it
104
open now
12
in phase 3
15
first study started
1990

How each study uses Isotretinoin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Isotretinoin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
7 May 1982 · ACCUTANE · NDA 018662 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Isotretinoin
69
oral isotretinoin
7
13-cis retinoic acid
4
Isotretinoin capsules
3
Isotretinoin (13-cis-retinoic acid)
2

Brand

Accutane
15
Amnesteem
3
Claravis
2
Sotret
2
ABSORICA
1

Development codes

RO-43
2
PAT-001
1

Other names

13-cis-retinoic acid
11

Studies by the year they started

101 studies that test it; most in 2011 (7)

Studies that test Isotretinoin, by start year
YearStudies
19901
19911
19921
19931
19961
19981
19991
20001
20016
20023
20031
20043
20053
20076
20082
20093
20104
20117
20123
20132
20142
20154
20163
20172
20185
20192
20204
20217
20223
20233
20244
20257
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
26
Phase 2
38
Phase 3
15
Phase 4
16
No phase
15

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 91

Children's Oncology Group (6) · M.D. Anderson Cancer Center (4) · Dr. Reddy's Laboratories Limited (4) · National Cancer Institute (NCI) (3) · University of Washington (3) · Eastern Cooperative Oncology Group (3) · Federal University of São Paulo (3) · Kafrelsheikh University (3)

Often tested with

Tested in the same studies.

Carboplatin (7) · Etoposide (6) · Temozolomide (4) · Cyclophosphamide (4) · Doxorubicin (4) · Filgrastim (4) · Dinutuximab (3) · Irinotecan (3)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 1 in phase 3

Studies that test Isotretinoin, phase 3 first.

Studies

Open first, then newest update. How each study uses Isotretinoin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 104

See all 104 studies that test Isotretinoin →

Given beside what is tested · 25 — Isotretinoin is usual care or a partner of the new treatment

Showing 20 of 25.

As the comparator · 5 — what is tested is compared with Isotretinoin

Codes

What other systems call Isotretinoin · ClinicalTrials.gg INT008470

  • MeSH (NLM) D015474IsotretinoinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) EH28UP18IFISOTRETINOINConfirmed FDA, NLM, Wikidata
  • RxNorm 6064Confirmed FDA, Wikidata
  • Wikidata Q287029isotretinoinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C603IsotretinoinOne source FDA
  • DrugBank DB00982One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.